Bioequivalence Trial of Alprazolam 2 mg Tablets

Clinical trial NCT01745575 · COMPLETED

Trial details

NCT number: NCT01745575
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anxiety Disorders

Start date: 2010-03-28
Primary completion: 2010-04-05
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.